Send Inquiry

Request To Call Back

Mylan Myaza Azacitidine For Injection

Name: Mylan Myaza Azacitidine For Injection
Brand: BALAJI CHEMICAL STORES
Price: 1000.0 INR
Availability: InStock

Price 1000.0 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

Mylan Myaza Azacitidine For Injection Specification

Dosage Form
Powder for Injection

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Treatment of Myelodysplastic Syndromes (MDS)

Origin of Medicine
India

Salt Composition
Azacitidine 100 mg

Packaging Type
Vial, packed in carton box with insert

Brand Name
MyAza

Life Span
Refer to package for expiry

Drug Type
Prescription Only (Rx)

Ingredients
Azacitidine

Physical Form
Injection (Lyophilized Powder for Reconstitution)

Function
Anticancer (Antineoplastic agent)

Recommended For
Patients with Myelodysplastic Syndromes (MDS)

Dosage
As prescribed by physician; typical starting dose is 75 mg/m2 daily for 7 days in 28-day cycles

Dosage Guidelines
For subcutaneous or intravenous use only

Suitable For
Adult

Quantity
100 mg/vial

Storage Instructions
Store below 25C, protect from light; keep out of reach of children

Reconstitution
Requires reconstitution with sterile water prior to administration

Therapeutic Class
Antineoplastic (Chemotherapy)

Dispensing Mode
Single-dose vial

Marketed By
Mylan Pharmaceuticals Pvt. Ltd.

Strength
100 mg/vial

Route of Administration
Subcutaneous or Intravenous

Appearance
White to off-white lyophilized powder

Language on Label
English and Hindi

Prescription Needed
Yes

Mylan Myaza Azacitidine For Injection Trade Information

Minimum Order Quantity
10 Boxes

Delivery Time
5-7 Days

About Mylan Myaza Azacitidine For Injection

Azacitidine for injection is a nucleoside analog used to treat myelodysplastic syndromes and acute myeloid leukemia. It restores normal blood cell production by inhibiting abnormal DNA methylation. Administered subcutaneously or intravenously, it improves survival, delays disease progression, and reduces transfusion dependence.

Targeted Chemotherapy for MDS

Myaza Azacitidine functions as an antineoplastic agent, designed specifically for adult patients with Myelodysplastic Syndromes. By interfering with abnormal cell growth in the bone marrow, it helps improve blood cell counts and can delay disease progression. This targeted therapy is suitable for hospital or clinic administration under the supervision of a qualified physician.

Safe Administration and Handling

Each vial of Myaza contains a powder formulation that requires careful reconstitution with sterile water before injectable use. It is intended for single use and should only be administered subcutaneously or intravenously by a healthcare professional. Proper storage below 25C and protection from light ensure medication integrity.

Prescription-Only and Patient-Centric

Myaza is available by prescription only, ensuring that patients receive tailored dosing and monitoring from their healthcare provider. Its packaging, clear labeling in both English and Hindi, and detailed insert enable proper usage and safety for adult patients who meet the indications for the product.

FAQ's of Mylan Myaza Azacitidine For Injection:

Q: How is Mylan Myaza Azacitidine administered to patients?

A: Myaza Azacitidine is administered either subcutaneously (under the skin) or intravenously (into a vein) after reconstitution with sterile water. Administration should be performed only by a healthcare professional following your doctor's instructions.

Q: What conditions is Myaza Azacitidine indicated for?

A: Myaza is indicated for the treatment of adults diagnosed with Myelodysplastic Syndromes (MDS), a group of disorders caused by poorly formed or dysfunctional blood cells.

Q: When should Myaza Azacitidine be taken and how often?

A: Your doctor will prescribe the dosing schedule. The typical starting protocol is 75 mg/m2 once daily for seven days, repeated every 28 days, but the dose may be adjusted based on your individual condition and response.

Q: Where should Myaza Azacitidine be stored before use?

A: Store the vial below 25C, away from light, and always keep it out of reach of children. Do not use the vial after the expiration date printed on the package.

Q: What is the process for preparing Myaza Azacitidine for administration?

A: The lyophilized powder must be reconstituted with sterile water for injection, as instructed in the package insert, and prepared by trained healthcare personnel in a clinical setting. Never attempt to reconstitute or inject the medicine yourself.

Q: What are the benefits of using Myaza Azacitidine for MDS patients?

A: Myaza helps control the growth of abnormal cells in the bone marrow, potentially improving blood counts and decreasing symptoms related to MDS, which may enhance quality of life and clinical outcomes when used as prescribed.

Q: Is a prescription required to obtain Myaza Azacitidine?

A: Yes, this medication is available only by prescription from a licensed healthcare provider, ensuring proper patient selection, dosage, and monitoring throughout treatment.

Tell us about your requirement